Literature DB >> 20445167

L-histidine decarboxylase and Tourette's syndrome.

A Gulhan Ercan-Sencicek1, Althea A Stillman, Ananda K Ghosh, Kaya Bilguvar, Brian J O'Roak, Christopher E Mason, Thomas Abbott, Abha Gupta, Robert A King, David L Pauls, Jay A Tischfield, Gary A Heiman, Harvey S Singer, Donald L Gilbert, Pieter J Hoekstra, Thomas M Morgan, Erin Loring, Katsuhito Yasuno, Thomas Fernandez, Stephan Sanders, Angeliki Louvi, Judy H Cho, Shrikant Mane, Christopher M Colangelo, Thomas Biederer, Richard P Lifton, Murat Gunel, Matthew W State.   

Abstract

Tourette's syndrome is a common developmental neuropsychiatric disorder characterized by chronic motor and vocal tics. Despite a strong genetic contribution, inheritance is complex, and risk alleles have proven difficult to identify. Here, we describe an analysis of linkage in a two-generation pedigree leading to the identification of a rare functional mutation in the HDC gene encoding L-histidine decarboxylase, the rate-limiting enzyme in histamine biosynthesis. Our findings, together with previously published data from model systems, point to a role for histaminergic neurotransmission in the mechanism and modulation of Tourette's syndrome and tics. 2010 Massachusetts Medical Society

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20445167      PMCID: PMC2894694          DOI: 10.1056/NEJMoa0907006

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  20 in total

Review 1.  Molecular mechanisms of human hypertension.

Authors:  R P Lifton; A G Gharavi; D S Geller
Journal:  Cell       Date:  2001-02-23       Impact factor: 41.582

2.  Detection of large-scale variation in the human genome.

Authors:  A John Iafrate; Lars Feuk; Miguel N Rivera; Marc L Listewnik; Patricia K Donahoe; Ying Qi; Stephen W Scherer; Charles Lee
Journal:  Nat Genet       Date:  2004-08-01       Impact factor: 38.330

Review 3.  Pathophysiology of Tourette's syndrome: striatal pathways revisited.

Authors:  Esen Saka; Ann M Graybiel
Journal:  Brain Dev       Date:  2003-12       Impact factor: 1.961

4.  Slitrk1-deficient mice display elevated anxiety-like behavior and noradrenergic abnormalities.

Authors:  K Katayama; K Yamada; V G Ornthanalai; T Inoue; M Ota; N P Murphy; J Aruga
Journal:  Mol Psychiatry       Date:  2008-09-16       Impact factor: 15.992

5.  The production of 53-55-kDa isoforms is not required for rat L-histidine decarboxylase activity.

Authors:  John V Fleming; Timothy C Wang
Journal:  J Biol Chem       Date:  2002-10-31       Impact factor: 5.157

6.  Mice lacking histidine decarboxylase exhibit abnormal mast cells.

Authors:  H Ohtsu; S Tanaka; T Terui; Y Hori; Y Makabe-Kobayashi; G Pejler; E Tchougounova; L Hellman; M Gertsenstein; N Hirasawa; E Sakurai; E Buzás; P Kovács; G Csaba; M Okada; M Hara; L Mar; K Numayama-Tsuruta; S Ishigaki-Suzuki; K Ohuchi; A Ichikawa; A Falus; T Watanabe; A Nagy
Journal:  FEBS Lett       Date:  2001-07-27       Impact factor: 4.124

7.  Increased methamphetamine-induced locomotor activity and behavioral sensitization in histamine-deficient mice.

Authors:  Yasuhiko Kubota; Chihiro Ito; Eiichi Sakurai; Eiko Sakurai; Takehiko Watanabe; Hiroshi Ohtsu
Journal:  J Neurochem       Date:  2002-11       Impact factor: 5.372

Review 8.  New functions of histamine found in histidine decarboxylase gene knockout mice.

Authors:  Hiroshi Ohtsu; Takehiko Watanabe
Journal:  Biochem Biophys Res Commun       Date:  2003-06-06       Impact factor: 3.575

9.  Changes in motoric, exploratory and emotional behaviours and neuronal acetylcholine content and 5-HT turnover in histidine decarboxylase-KO mice.

Authors:  E Dere; M A De Souza-Silva; R E Spieler; J S Lin; H Ohtsu; H L Haas; J P Huston
Journal:  Eur J Neurosci       Date:  2004-08       Impact factor: 3.386

10.  The functional neuroanatomy of Tourette's syndrome: an FDG PET study III: functional coupling of regional cerebral metabolic rates.

Authors:  K J Jeffries; C Schooler; C Schoenbach; P Herscovitch; T N Chase; A R Braun
Journal:  Neuropsychopharmacology       Date:  2002-07       Impact factor: 7.853

View more
  122 in total

1.  Rare copy number variants in tourette syndrome disrupt genes in histaminergic pathways and overlap with autism.

Authors:  Thomas V Fernandez; Stephan J Sanders; Ilana R Yurkiewicz; A Gulhan Ercan-Sencicek; Young-Shin Kim; Daniel O Fishman; Melanie J Raubeson; Youeun Song; Katsuhito Yasuno; Winson S C Ho; Kaya Bilguvar; Joseph Glessner; Su Hee Chu; James F Leckman; Robert A King; Donald L Gilbert; Gary A Heiman; Jay A Tischfield; Pieter J Hoekstra; Bernie Devlin; Hakon Hakonarson; Shrikant M Mane; Murat Günel; Matthew W State
Journal:  Biol Psychiatry       Date:  2011-12-14       Impact factor: 13.382

Review 2.  The genetics of Tourette disorder.

Authors:  Matthew W State
Journal:  Curr Opin Genet Dev       Date:  2011-01-27       Impact factor: 5.578

3.  Open conformation of human DOPA decarboxylase reveals the mechanism of PLP addition to Group II decarboxylases.

Authors:  Giorgio Giardina; Riccardo Montioli; Stefano Gianni; Barbara Cellini; Alessandro Paiardini; Carla Borri Voltattorni; Francesca Cutruzzolà
Journal:  Proc Natl Acad Sci U S A       Date:  2011-12-05       Impact factor: 11.205

Review 4.  The genetics of Tourette syndrome.

Authors:  Hao Deng; Kai Gao; Joseph Jankovic
Journal:  Nat Rev Neurol       Date:  2012-03-13       Impact factor: 42.937

Review 5.  Advances in understanding and treatment of Tourette syndrome.

Authors:  Kevin St P McNaught; Jonathan W Mink
Journal:  Nat Rev Neurol       Date:  2011-11-08       Impact factor: 42.937

Review 6.  Neurobiological substrates of Tourette's disorder.

Authors:  James F Leckman; Michael H Bloch; Megan E Smith; Daouia Larabi; Michelle Hampson
Journal:  J Child Adolesc Psychopharmacol       Date:  2010-08       Impact factor: 2.576

Review 7.  Genetics and genomics of psychiatric disease.

Authors:  Daniel H Geschwind; Jonathan Flint
Journal:  Science       Date:  2015-09-24       Impact factor: 47.728

Review 8.  Systematic review: pharmacological treatment of tic disorders--efficacy of antipsychotic and alpha-2 adrenergic agonist agents.

Authors:  Hannah Weisman; Imraan A Qureshi; James F Leckman; Lawrence Scahill; Michael H Bloch
Journal:  Neurosci Biobehav Rev       Date:  2012-10-23       Impact factor: 8.989

9.  Effectiveness of a web-based protocol for the screening and phenotyping of individuals with Tourette syndrome for genetic studies.

Authors:  Crystelle A Egan; Susan E Marakovitz; Julia A O'Rourke; Lisa Osiecki; Cornelia Illmann; Lauren Barton; Elizabeth McLaughlin; Rachel Proujansky; Justin Royal; Heather Cowley; Martha Rangel-Lugo; David L Pauls; Jeremiah M Scharf; Carol A Mathews
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2012-10-22       Impact factor: 3.568

10.  Striatal Signaling Regulated by the H3R Histamine Receptor in a Mouse Model of tic Pathophysiology.

Authors:  Maximiliano Rapanelli; Luciana Frick; Kantiya Jindachomthong; Jian Xu; Hiroshi Ohtsu; Angus C Nairn; Christopher Pittenger
Journal:  Neuroscience       Date:  2018-09-29       Impact factor: 3.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.